The present paper deals with the pteridine metabolism of Drosophila which can,t be presented by a detailed investigation on the enzymatic reduction of sepiapterin.
Material and Methods
Prepupae of wild-type (Oregon-R) in Drosophila melanogaster were used for the preparation of purified pterine reductase.
Sepiapterin and other pteridine derivativessuch as 2-amino-4-hydroxypteridine (AHP), isoxanthopterin (IXP), biopterin (BP) and 2-amino-4-hydroxypteridine-6-carboxylic acid (PCA), were all provided by Dr. Nawa. Triphosphopyridine nucleotide (TPN) was purchased from Nutritional Biochemicals Corporation, U.S.A.
Reduced triphosphopyridine nucleotide (TPNH) was prepared by the reduction of TPN with TPN-transhydrogenase partially purified from chicken heart extract, in the presence of citrate and Mg-. Five milliliters of reaction mixture containing 5 mg of TPN, 0.01 M potassium phosphate buffer, pH 6.8, 3.3 mM of MgSO4, 3.3 mM of citrate, and 0.1 ml of chicken heart enzyme solution were incubated at room temperature until the absorption at 340 m,a reached a constant value.
After the addition of 0.1 ml of 1 M NaOH, the mixture was immersed in a boiling water bath for 2 minutes and then centrifuged. The final concentration of TPNH in the supernatant was determined spectrophotometrically.
The enzymatic conversion of sepiapterin into tetrahydro-form, which will be described in detail below, and that of TPNH into TPN were estimated by spectrophotometrical measurement of the reduction of extinction at 410 m,a for the former and that at 340 m,u for the latter.
The chemical natures of pteridines obtained from this experiment were determined by comparisons of their Rf values and ultraviolet absorption spectra with those of the synthesized pteridines.
Experimental results
Purification of pterine reductase: Fresh wild-type prepupae of D. melanogaster were homogenized at 0°C for 15 seconds with an equal weight of cold 0.1 M potassium phosphate buffer, pH 6.2. After centrifugation at 0°C, the supernatant was washed several times with cold acetone (-15°C) and dried in vacuo. The water extract of the crude acetone powder was treated with Dowex 1-chloride in an ice bath to remove cofactors. The precipitate at pH 5.0 was centrifuged off. The reductase was further purified by fractionation with cold acetone. The fraction between 40 and 60% acetone containing almost all of the activity was washed twice with cold acetone and dried in vacuo. The re-extract with cold distilled water (10 mg/ml) was centrifuged and the residue was discarded. The supernatant had some TPNH-oxidizing activity.
Therefore, further purification was followed by fractionation with ammonium sulfate.
The fraction between 50 and 65% ammonium sulfate in an ice bath was collected by centrifugation and the precipitate was dissolved with cold distilled water-
The residue was centrifuged off. The final supernatant was used as an enzyme solution for the experiment.
It seemed to be completely free from TPNH-oxidizing and Fig. 1 . Optimum rate of the reaction occurred at about pH 6.5 (Fig. 2) . The reaction velocity in the absence of oxygen was more rapid than that in its presence.
A violent aeration inhibited completely the reaction; such phenomenon might be due to the decomposition of sepiapterin and TPNH. An effect of phosphate and citrate buffers on the reaction velocity was tested, but a difference between them was detected scarcely.
The purified reductase was unstable at room temperature in the presence of oxygen and its half-life was about one hour. However, the reductase was considerably stable at 0°C in the absence of oxygen and it could be stored for a month.
Various inhibitors for the reaction was tested ; 2, 4-dinitrophenol (6.5X10-5M) inhibited completely, and folate showed about 40% inhibition in a concentration from 1.6 x 10-5 M to 4.3 x 10-' M. Potassium cyanide (3.3 X 10-4 M) inhibited scarcely. Both riboflavin (3.3 x 10-5 M) and flavin mononucleotide (2.0 x 10-4 M) did not affect to the reaction.
Cystein (2.3 x 10-6 M) was used as SH-group, but it did not inhibit unexpectedly. According to the previous reports of the present author (1960, 1961 c) , the extract of Hnr3 male has contained a high concentration of inhibitor.
This substance was isolated and purified chromatographically. It was stable for a high temperature and it was chromatographically indistinguishable from biopterin (see Table 2 ). However, differing from biopterin, it was scarcely photo-decomposed by visible light. The purified inhibitor showed 80% inhibition even at the maximum rate. At that time, biopterin showed about 70% inhibition. The crude extract from Hnr3 strain completely inhibited the reaction. Therefore, it has remained to be elucidated whether or not this pteridine is only an actual inhibitor in Hnr3 male." Estimation of product enzymatically reduced from sepiapterin: As mentioned above, the purified enzyme could convert sepiapterin (dihydro-from) in the presence of Table 1 . Stoichiometry of pterine reductase* *} The enzyme solution, 0.3 ml, was incubated at 20°C in a medium containing 27.8µM sepiapterin, 45.7µM TPNH and 0.01M citrate buffer, pH 6.5. The total volume was 3 ml.
TPNH, and that could be detected spectrophotometrically by disappearance of theyellow color and fluorescence characteristic of sepiapterin. In order to identify what was the actual product from this enzymatic reaction, the reduction of extinction at_ 410 mit for sepiapterin and that at 340 m/c for TPNH were measured stoichiometrical ly. The result was shown in Table 1 . Except for the value at 10 minutes of incubation time, the molar ratio of sepiapterin to TPNH consumed in this reaction medium was nearly 1.0. As shown in Fig. 3 , the curve of the reaction product from sepiapterin was very similar to those of tetrahydropteridines reported by Viscontini and Weilenmann (1958) and Kaufman (1959) . When the reaction mixture was exposed to air, the yellow color and fluorescence characteristic of sepiapterin appeared again except for partial decomposition.
From these results, it is suggested that the reaction product might be tetrahydro-form of sepiapterin, i.e. tetrahydrosepiapterin, and that the purified enzyme is a true reductase.
Estimation of the products further converted from tetrahydrosepiapterin: Tetrahydrosepiapterin enzymatically produced was gradually converted further into anotherproduct, probably by non-enzymatic reaction, in the same reaction mixture under the absence of oxygen. This phenomenon was detected by appearance of blue fluorescence which could not be found in the previous step. These products were separated chromatographically; the majority was a pteridine derivative with purplish blue fluorescence and the residue in a trace amount contained a yellow fluorescent pteridine and two kinds of blue fluorescent ones.
I. Estimation of the main product non-enzymatically converted from tetrahydrosepiapterin in the absence of oxygen: For convenience, the main product non-enzymatically converted from tetrahydrosepiapterin in the absence of oxygen, is henceforth referred to as compound A. Compound A, which was converted from tetrahydrosepiapterin enzymatically produced from 10 mg of sepiapterin, was purified as follows; the solution was applied to a column (4 x 40 cm) of cellulose powder (Toyo Roshi, and developed with distilled water.
The fraction of a main blue fluorescent band was collected and concentrated in vacuo to a small volume (about 10 ml), and it was paper chromatographed (Toyo Roshi, No. 26) with a mixture of n-butanol, acetic acid and water (4:1:1).
After drying, the appropriate band corresponding to the main blue fluorescent substance was eluted with water. The concentrated solution was applied again to a column of cellulose powder mentioned above and developed with water.
The fraction of main blue fluorescent band was collected and then it was dried in vacuo avoiding photolysis.
Such purification gave about 1 mg of compound A.
A. Ultraviolet absorption spectra and RI value of compound A: The ultraviolet absorption spectra of compound A were shown in Fig. 4 . These spectra were very similar to those of biopterin which has been reported by Forrest and Mitchell (1955) ,. Patterson et al. (1956) and Viscontini et al. (1958) . Some Rf values of paper-chromatograms with various solvents are given in Table 2 , compared with those of authentic Wave length Fig. 4 . Ultraviolet absorption spectra of compound A: ----at pH 11.0; ----at pH 1 .0.
T. TAIRA pteridines.
Even by these values, compound A is also indistinguishable from biopterin.
B. Oxidation of compound A with periodate: Periodate oxidation of compound A was carried out as follows; a solution of compound A (55,ug) in 2% sodium bicarbonate (0.2 ml) was treated with 0.04% periodate (0.1 ml) in an ice bath. Aliquots (0.2 ml) were withdrawn and quenched in 0.5% arsenite (0.1 ml). Then, the amount of acetaldehyde was determined by the color development with p-hydroxydiphenyl in sulfuric acid (Block and Bolling 1939; Nawa 1960) . Aliquots (0.2 ml) were mixed with sulfuric acid (3 ml) and 2%o CuSO4 (0.05 ml) in an ice bath. Then, 1.5% p-hydroxydiphenyl reagent (0.05 ml) was dropped in and the mixture was stood at 30°C for 40 minutes.
The color developed was estimated at 570 mg. A given mole of threonine was used as a standard for the quantitative measurement of acetaldehyde. The yield of acetaldehyde, calculated from the standard value, was 50.2,ug in acidic solution and 7.4 ug in alkaline solution, at 16 hours incubation. Another product from the oxidation was identified to be 2-amino-4-hydroxypteridine-6-carboxylic acid (PCA) by the ul- 3): Reduction products with NaBO4 in neutral solution.
4): Photo-decomposed products after reduction with NaBO4 in neutral solution.
traviolet absorption spectra (Fig. 5) and Rf values of various chromatograms (see Table 2 ).
•C . Reduction of compound A with sodium borohydride:
Reduction of compound A with sodium borohydride was performed as follows; when a solution of compound A (55 sag) in 0.01 N acetic acid (1 ml) was treated with sodium borohydride (0.1 mg), a purplish blue fluorescence of the solution immediately changed to a light blue fluorescence, but the fluorescence did not diminish.
Some Rf values of this solution were also shown in Table 2 . The product reduced with sodium borohydride was quite indistinguishable from the original compound A and biopterin. It has been reported by Viscontini and Weilenmann (1958) , Kaufman (1959) and Nawa (1960) that dihydro--pteridines seem to be reduced to the corresponding tetrahydro-form by the action of sodium borohydride. Therefore, the present result suggests that compound A may not be dihydro-form, although it remains the question that sodium borohydride may not act on dihydropteridines having the same substituent as biopterin.
D. Photo-decomposition and oxygen uptake: Compound A in neutral solution was photo-decomposed easily by visible light into PCA and acetaldehyde. The former was confirmed chromatographically (see Table 2 ). The latter was determined by the color development with p-hydroxydiphenyl in sulfuric acid, as described above.
The oxygen uptake during photolysis of compound A was measured manometrical- ly. Neutral solution (5 ml) contained compound A (330,ug) was shaken in a Warburg flask at 20°C. At various time-intervals, oxygen uptake was measured, the amounts of PCA produced were calculated by using the known extinction constant at 310 mA at pH 7 and the amounts of acetaldehyde were determined by the procedure mentioned above. These results were shown in Table 3 . In the experimental results, the molar ratio of oxygen consumed and compound A used showed the values between 1.07 and. 1.54. The variable ratio may be due to some impurities. If the ratio should be presumed to be 1, it suggests that compound A is biopterin as shown in the following scheme (I). On the other hand, in the case where the ratio should be presumed to be 1.5, it suggests that compound A is dihydrobiopterin as shown in the following scheme (II). However, the present data are not enough to decide whether compound A is biopterin or its dihydro-form.
II. Estimation
of main products non-enzymatically converted from tetrahydrosepiapterin in the presence of oxygen: Besides compound A mentioned above, a trace of other pteridines was isolated from the products non-enzymatically converted in the absence of oxygen.
In the presence of oxygen, three kinds of pteridines were the major products instead of compound A. One of the blue fluorescent pteridine among them was identified to be 2-amino-4-hydroxypteridine (AHP), because it was easily converted into isoxanthopterin by xanthine oxidase. Another blue fluorescent pteridine among them was chromatographically identified to be 2-amino-4-hydroxypteridine-6-carboxylic acid (PCA). These facts suggest that AHP found in vivo is converted from tetrahydrosepiapterin by non-enzymatic oxidation. Small amount of yellow fluorescent pteridine was also detected, but it remained to be elucidated whether it is an original sepiapterin or the second yellow compound reported by Forrest et al. (1959 a, b) .
Discussion
During the past few years, the evidences have been accumulated that the eyepigments except for the brown one are the products of the pteridine metabolism. Many kinds of pteridine derivatives found in Drosophila have been reported by several investigators as follows: 2-amino-4-hydroxypteridine (AHP), biopterin (BP), isoxanthopterin (IXP), sepiapterin (SP), drosopterin (DP), isodrosopterin, neodrosopterin, isosepiapterin (second yellow compound) and xanthopterin.
Five of them, such as AHP, BP, IXP, SP and DP, were most commonly obtained from this insect, at a considerable high concentration. Only on DP among these pteridines, its chemical structure has not been determined yet.
The metabolic relationship among these pteridines attracted attention of several .authors.
However, only the conversion of AHP into IXP by pterine or xanthine dehydrogenase has been clarified by Forrest et al. (1956) , Nawa et al. (1958) , Glassman -and Mitchell (1959) and Hubby and Forrest (1960) independently. Since the present author (1960, 1961 a) reported on Drosophila pterine reductase which can convert -sepiapterin into tetrahydro-form, a cue toward clarification of another metabolic relationship between pteridine derivatives of Drosophila has been found. As mentioned in the experimental results, the conversion of sepiapterin is catalyzed by pterine reductase obtained from Drosophila, in the presence of TPNH (reduced triphosphopyridine nucleotide) as a co-factor, and a compound characteristic of typical tetrahydropteridine is produced. In this reaction, one mole of TPNH is necessary for the reduction of one mole of sepiapterin.
Therefore, it leads to a conclusion that the tetrahydro-form is tetrahydrosepiapterin. An inhibitor for the conversion was extracted from Hn" strain while not from the wild-type strain.
It was chromatographically indistinguishable from biopterin.
This shows biochemically that the reaction of pterine reductase is controlled genetically. Further conversion of tetrahydrosepiapterin into dihydrobiopterin may be performed by the transposition of two hydrogen atoms in a molecule from the 5,6-position of pteridine ring to the CO-bond in lactyl-substituent of sepiapterin. However, the .dihydrobiopterin has not been actually detected from the reaction products, although the existence of dihydrobiopterin is assumed from the experimental results of oxygen uptake during photolysis.
Probably, it may be difficult to separate chromatographically from biopterin. Ziegler-Gunder (1960) has reported on a dihydrobiopterin glucoside corresponding to tetrahydrobiopterin glucoside found in Drosophila eyes, and he has suggested that the reciprocal transfer of hydrogen between them might closely relate to the photo-sensitivity of Drosophila eyes as " photolabile pteridine ". Furthermore, the conversion from dihydrobiopterin to biopterin will be followed by dehydrogenization of one mole. Thus, the metabolic pathway from sepiapterin to biopterin in this insect has been established through the tetrahydrosepiapterin.
In the presence of oxygen, the tetrahydrosepiapterin enzymatically produced from , sepiapterin, is converted by non-enzymatic oxidation into AHP and 2-amino-4-hydro-. xypteridine-6-carboxylic acid (PCA) in vitro. These pteridines are the main product in this case instead of compound A in the absence of oxygen.
These facts suggest that AHP found in vivo is easily converted from tetrahydrosepiapterin by nonenzymatic oxidation.
In this reaction, furthermore, a small portion of sepiapterin (dihydro-form) is reverted from the tetrahydrosepiapterin by autoxidation. On the basis of these experimental results, the following metabolic relationship among pteridine derivatives found in D. melanogaster could be presented:
Enzymes capable of reducing folic acid or dihydrofolate were obtained from chicken liver by Futterman (1957) and Osborn and Huennekens (1958) , from sheep liver by Peters and Greenberg (1958) and from Clistridium sticklandii by Wright et al. (1958) . Zakrzewski (1960 a, b) has reported on the purification, properties and substrate specificity of folic acid reductase from chicken liver.
Reductase from chicken liver purified by the present author can convert sepiapterin into tetrahydro-form as well as folate. However, it seems to prefer sepiapterin to folate as a substrate.
The difference in the results between the above investigators and the present author may be due to optimum pH, i. e. the optimum rate of the reaction with regard to the reduction of sepiapterin occurs at pH 6.5 and that of folate occurs at pH 5.0, as Zakrzewski (1960 a) has reported. Except for this point, both reductions of sepiapterin and folate are quite similar to each other.
However, it has remained to be resolved as to whether or not both reductions have been catalyzed by the same enzyme. Taira and Nawa (1958) has reported on the folic acid contained in both pupae and adult flies of D. melanogaster, and they have not agreed with an assumption that pteridine derivatives found in this insect mentioned above might be derived from folic acid. Based on the present evidences as regard to the reduction system of folic acid, we may suppose that the Drosophila reductase catalyzes the conversion of biopterin into tetrahydropterin through dihydro-form. By this time , however, the investigations have shown that the reductase can not attack biopterin as a substrate .
Regarding the reductase activity, nevertheless, there may be some relationships between the metabolisms of pteridine mentioned above and folic acid .
A high correlation between amounts of sepiapterin and biopterin and a negative correlation between amounts of sepiapterin and drosopterin, have been found in " sepiapterinic strains " of D. melanogaster (Taira 1961 b) . These findings suggest that sepiapterin is a precursor of drosopterin.
If it is so, what mechanism underlies the process of drosopterin formation is remained to be elucidated. Finally, it would be added into the present discussion that the Drosophila reductase can not attack other pteridine derivatives, such as AHP, PCA, DP and BP, except for SP.
Summary
The conversion of sepiapterin by pterine reductase obtained from Drosophila melanogaster was investigated biochemically. Molar ratio of reduced triphosphopyridine nucleotide as a cofactor to sepiapterin as a substrate on this enzymatic reaction, was 1.0. The spectra of the reaction product were very similar to those of tetrahydropteridine.
These facts suggest that the reaction product is tetrahydrosepiapterin. The products further converted from the tetrahydrosepiapterin by non-enzymatic oxidation were analyzed biochemically.
In the absence of oxygen, the main product, compound A, was indistinguishable from biopterin in the chemical natures examined.
In the presence of oxygen, the products of 2-amino-4-hydroxypteridine and 2-amino-4-hydroxypteridine.6-carboxylic acid were confirmed. From these experimental results, the metabolic relationships among pteridine derivatives found in Drosophila were clarified. A plausible scheme of pteridine metabolism is as follows: Sepiapterin Tetrahydrosepiapterin = [Dihydrobiopterin] Biopterin l 2-amino-4-hydroxypteridi ne
